Cite
HARVARD Citation
Gros, B. et al. (2023). Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort. United European Gastroenterology journal. 11 (2), pp. 179-188. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gros, B. et al. (2023). Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort. United European Gastroenterology journal. 11 (2), pp. 179-188. [Online].